Physician profile
Antonio Martinez
NPI 1497012926
$241.89
in general payments reported to CMS, 2019-2025
8 companies · $50.57 in 2025
The $50.57 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.56 · 2022: $13.05 · 2023: $76.78 · 2024: $85.93 · 2025: $50.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $50.57 | 2025 | Xtandi |
| Novo Nordisk INC | $47.72 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $47.33 | 2023-2024 | Mounjaro, Zepbound |
| Abiomed | $33.12 | 2024 | Impella |
| Exact Sciences Corporation | $17.47 | 2024 | Cologuard Collection Kit |
| Dexcom, INC. | $17.00 | 2023 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $15.56 | 2019 | |
| Abbvie INC. | $13.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.